Vaccine Assessment and Management for Workers: Present, Future, and Predictor Indicators

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (15 August 2021) | Viewed by 762

Special Issue Editors

E-Mail Website
Guest Editor
Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Interests: mutagenic and carcinogenic effects of xenobiotics, asbestiform fibers and radiation; work organizations; ergonomics; psycho-physical wellbeing; health promotion in the workplace
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Commodity Sciences, Department of Economic & Business, University of Catania, Catania, Italy
Interests: quality and environmental management systems; life cycle assessment; circular economy; eco sustainability instruments

E-Mail Website
Guest Editor
Entrepreneurship and Innovative Management, Economic & Business Department, University of Catania, Catania, Italy
Interests: start ups and entrepreneurial ecosystem; technology transfer process; health management

Special Issue Information

Dear Colleagues,

Vaccine-preventable diseases (VPD) occur endemic and epidemic and continue to impact the workforce's economy and health. Also, outbreaks often occur in specific work settings, such as hospitals, transport, construction sites, offices.

One of a major aim of occupational medicine is to prevent VPD among workers to protect collective health. In conjunction with health protection, there is social and economic protection. The loss of days of work can damage the financial and social impact through apposite indicators to applicate in database to build up a risk management model and a decision support system for identifying, evaluating and mitigating the occupational risk in order to promote safety, well-being and quality of life of workers in pandemic and post-pandemic times.

Reducing the risk from the VPD by workers due to stress and burnout, is crucial for healthcare organizations because they should provide a healthcare service.

In conclusion, the objective of this Special Issue is disseminate original research, reviews and note on vaccine assessment and management for workers in order to evaluate present management and indicate the future solutions and predictor indicators. 

Prof. Dr. Caterina Ledda
Prof. Dr. Venerando Rapisarda
Dr. Agata Matarazzo
Dr. Carmela Schillaci
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • Vaccine
  • Management
  • Social and economic indicators
  • Worker
  • Workplace
  • Injuries

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop